Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival,…

By C. Yeo, John L. Cameron, K. Lillemoe, T. Sohn, K. Campbell, P. Sauter, J. Coleman, R. Abrams, R. Hruban. Annals of Surgery, 2002

841 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/0b036681eb206da885b17c40b9411c2a1ef0516b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. D. Tuveson
2. T. Jacks
3. A. Rustgi

Citations in the corpus

• Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. (2003, background): “The vast majority of even highly selected patients, possessing small primary lesions (less than 2 cm), disease-free resection margins, and negative lymph nodes, inevitably succumb to recurrent or metastatic disease (Allison et al., 1998; Yeo et al., 2002a).”
• Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy (2015, neutral): “The majority of patients who are selected to undergo potentially curative resection for small, localized lesions almost inevitably develop recurrent or metastatic disease (Yeo et al, 2002), presumably due to the presence of undetected micro-metastases at initial diagnosis.”
• One Thousand Consecutive Pancreaticoduodenectomies (2006, background): “Finally, a prospective randomized study was carried out in our institution evaluating pylorus-preserving pancreaticoduodenectomy without a retroperitoneal node dissection, versus a classic Whipple and a retroperitoneal lymphadenectomy, looking at their effect on long-term survival for patients with ”
• Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience (2004, methodology): “As part of a prospective, randomized trial, retroperitoneal lymphadenectomy and distal gastrectomy were used in some patients with an infiltrating carcinoma from 1996 through 2001.(18) All distal pancreatic resections included splenecAnnals of Surgery • Volume 239, Number 6, June 2004 IPMNs of the P”
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. (2005, background): “…VOL. 7 · COPYRIGHT © 2005 ELSEVIER INC. dergo complete surgical resection of their primary tumor, fiveyear survival can be as high as 20%–40%; however, even these highly selected patients eventually succumb to both locally recurrent and metastatic disease (Allison et al., 1998; Yeo et al., 2002a).”